Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia
Timothy Glidewell, Spatial Regional Account Manager at Bruker Spatial, reposted from The National Institutes of Health on LinkedIn:
”The latest NCI update on an experimental therapy for severe aplastic anemia is an important signal for anyone thinking about bone marrow failure, immune dysregulation, and why only some patients respond to treatment.
To truly unravel these questions, we need to see how stem/progenitor cells, stromal support cells, and immune effectors are organized and interacting in situ.
That’s where CosMx™ Spatial Molecular Imager can help—enabling single-cell, subcellular, whole-transcriptome views of rare cell populations within the marrow niche.
These insights can support translational teams working to understand mechanisms of response and resistance in severe, immune-mediated diseases.
If you’re in the Bay Area and would like to discuss how these spatial biology platforms could support your research, feel free to reach out!”
Quoting The National Institutes of Health‘s post:
”NEWS: An NIH clinical trial has shown promise for an experimental treatment for people with severe aplastic anemia, a life-threatening disorder with limited treatments.”
Read the full announcement here.
Stay updated on all scientific advances with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?